Enanta Pharmaceuticals | Nettoeinkommen



Net Income Veränderung Datum
AbbVie USD 1.29B 1.31B 2025-03
Amgen USD 1.73B 1.1B 2025-03
Arrowhead Research USD 370.44M 543.53M 2025-03
AstraZeneca USD 2.92B 1.42B 2025-03
Biogen USD 240.5M 26.2M 2025-03
Bristol-Myers Squibb USD 2.46B 2.38B 2025-03
Gilead Sciences USD 1.78B 529M 2024-12
GlaxoSmithKline GBP 1.62B 1.21B 2025-03
Halozyme Therapeutics USD 118.1M 18.92M 2025-03
Incyte USD 158.2M 43.01M 2025-03
Insmed USD -256583000 21.04M 2025-03
Ionis Pharmaceuticals USD -146938000 42.59M 2025-03
J&J USD 11B 7.57B 2025-03
Ligand Pharmaceuticals USD -42451000 11.36M 2025-03
Merck USD 5.08B 1.34B 2025-03
Neurocrine Biosciences USD 103.1M 26.7M 2024-12
Novartis USD 2.82B 371M 2024-12
Pfizer USD 2.97B 2.56B 2025-03
PTC Therapeutics USD -65886000 40.77M 2024-12
Roche Holding CHF 1.01B 2.12B 2024-12
Sarepta Therapeutics USD -447508000 606.56M 2025-03
Vertex Pharmaceuticals USD 913M 132.4M 2024-12



Enanta Pharmaceuticals Nettoeinkommen - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Jul 2025.